3B Blackbio Dx Limited (BOM:532067)
1,463.50
+54.10 (3.84%)
At close: Sep 25, 2026
3B Blackbio Dx Company Description
3B Blackbio Dx Limited manufactures and sells molecular diagnostic kits in India.
The company designs, develops, manufactures and commercializes qPCR assays, rapid diagnostic tests, NGS-based diagnostic kits, digital PCR assays, and nucleic acid extraction solutions for reliable testing of patient samples, as well as offers oncology and hematology, antimicrobial resistance, infectious diseases, human genetics, extraction, and rapid antigen kits under the TRUPCR, TRUNGS, and TRURAPID brand names; and technical support and training services.
3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
3B Blackbio Dx Limited
| Country | India |
| Founded | 1972 |
| Industry | Agricultural Chemicals |
| Employees | 86 |
| CEO | Dhirendra Dubey |
Contact Details
Address: 7-C, Industrial Area Bhopal, 462023 India | |
| Phone | 91 75 5258 6536 |
| Website | 3bblackbio.com |
Stock Details
| Ticker Symbol | 532067 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Dhirendra Dubey | Chief Executive Officer |
| Nikhil Dubey | Chief Financial Officer |